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Abstract
Background: Intoxication from the psychostimulant methamphetamine (METH) because of cardiovascular collapse
is a common cause of death within the abuse population. For obvious reasons, the heart has been taken as the
primary target for this METH-induced toxicity. The demonstration that failure of brain stem cardiovascular
regulation, rather than the heart, holds the key to cardiovascular collapse induced by the pesticide mevinphos
implicates another potential underlying mechanism. The present study evaluated the hypothesis that METH effects
acute cardiovascular depression by dampening the functional integrity of baroreflex via an action on brain stem
nuclei that are associated with this homeostatic mechanism.
Methods: The distribution of METH in brain and heart on intravenous administration in male Sprague-Dawley rats,
and the resultant changes in arterial pressure (AP), heart rate (HR) and indices for baroreflex-mediated sympathetic
vasomotor tone and cardiac responses were evaluated, alongside survival rate and time.
Results: Intravenous administration of METH (12 or 24 mg/kg) resulted in a time-dependent and dose-dependent
distribution of the psychostimulant in brain and heart. The distribution of METH to neural substrates associated
with brain stem cardiovascular regulation was significantly larger than brain targets for its neurological and
psychological effects; the concentration of METH in cardiac tissues was the lowest among all tissues studied. In
animals that succumbed to METH, the baroreflex-mediated sympathetic vasomotor tone and cardiac response
were defunct, concomitant with cessation of AP and HR. On the other hand, although depressed, those two
indices in animals that survived were maintained, alongside sustainable AP and HR. Linear regression analysis
further revealed that the degree of dampening of brain stem cardiovascular regulation was positively and
significantly correlated with the concentration of METH in key neural substrate involved in this homeostatic
mechanism.
Conclusions: We conclude that on intravenous administration, METH exhibits a preferential distribution to brain
stem nuclei that are associated with cardiovascular regulation. We further found that the concentration of METH in
those brain stem sites dictates the extent that baroreflex-mediated sympathetic vasomotor tone and cardiac
responses are compromised, which in turn determines survival or fatality because of cardiovascular collapse.
Background
The psychostimulant methamphetamine (METH; N-
methyl-O-phenylisopropylamine) is among the most
popular illegal drugs worldwide [1-4]. Based on records
between 1998 and 2001 from the Ministry of Justice,
Taiwan, it has been reported that this schedule II
controlled drug is being used by approximately 79.3% of
drug offenders in Taiwan [5]. Because METH enhances
alertness, concentration, energy, euphoria and libido, it
has become a well-known drug of abuse that leads to
severe societal and economical consequences [6,7]. The
best known pharmacological effects of METH are well
documented to be associated with brain sites that are
involved in the reward system [8-11] and neurodegen-
erative disease [11-13]. As such, nucleus accumbens
(NACC), globus pallidas (GPi), caudate nucleus (Cd),
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substantia nigra (SN) and ventral tegmental nucleus
(VTA) are among the most often mentioned brain tar-
gets for METH-induced psychological or neurological
responses [8-13].
METH intoxication is a common cause of death
within the abuse population [14,15]. In particular, severe
hypotension and bradycardia are often observed in
patients who exhibit acute METH intoxication [1,15,16],
with 100% mortality despite intensive care in a hospital
setting [1,17]. For obvious reasons, the heart has been
taken as the primary target for METH-induced cardio-
vascular toxicity. Thus, atrioventricular arrhythmia and
myocardial ischemia reportedly contribute to METH-
induced fatality [18]. Of note is that our laboratory [19]
demonstrated recently that failure of brain stem cardio-
vascular regulation, rather than the heart, holds the key
to cardiovascular collapse induced by the pesticide
mevinphos. This suggests that another target for
METH-induced cardiovascular toxicity may be brain
stem nuclei, including nucleus tractus solitarii (NTS)
and rostral or caudal ventrolateral medulla (RVLM or
CVLM) that are associated with the baroreflex, which is
responsible for the maintenance of stable blood pressure
and heart rate [20].
The present study evaluated the hypothesis that
METH effects acute cardiovascular depression by dam-
pening the functional integrity of baroreflex via an
action on brain stem nuclei that are associated with this
homeostatic mechanism. Based on evaluations of distri-
bution of METH in brain and heart on intravenous
administration, baroreflex responses and survival rate
and time, this hypothesis was validated.
Methods
Adult male Sprague-Dawley rats (275-315 g, n = 39)
purchased from the Experimental Animal Center of the
National Science Council and BioLASCO, Taiwan,
Republic of China were used. Rats were housed in an
Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC) International-accre-
dited animal facility under temperature control (24-25°
C) and 12-h light-dark cycle. Standard laboratory rat
chow and tap water were available ad libitum. All
experimental procedures carried out in this study were
approved by the Institutional Animal Care and Use
Committee of the Kaohsiung Chang Gung Memorial
Hospital (CGMH891071). Efforts were made to reduce
the number of animals used and to minimize animal
suffering during the experiment.
General preparation
Under an induction dose of pentobarbital sodium (50
mg/kg, i.p.), animals received preparatory surgery that
included tracheal intubation and cannulation of the
femoral artery and vein. During the recording session,
which routinely commenced 60 min after the adminis-
tration of pentobarbital sodium, animals received an
intravenous infusion of propofol (20-25 mg/kg/h;
Zeneca, Macclesfield, England), which provided satisfac-
tory maintenance of anesthesia while preserving the
capacity of central cardiovascular regulation [21]. Ani-
mals were allowed to breathe spontaneously with room
air, and body temperature was maintained at 37°C by a
heating pad.
Evaluation of baroreflex responses
Arterial pressure (AP) signals recorded from the femoral
artery were processed by an arterial blood pressure ana-
lyzer (APR31a; Notocord, Croissy-Sur-Seine, France)
and heart rate (HR) was derived instantaneously from
the systolic blood pressure (SBP) signals. To evaluate
brain stem cardiovascular regulation, the SBP signals
were subject simultaneously to on-line and real-time
spectral analysis (SPA10a; Notocord). We were particu-
larly interested in the low-frequency (LF; 0.25-0.8 Hz)
component because it takes origin from RVLM [22],
and its power density mirrors the prevalence of barore-
flex-mediated sympathetic neurogenic vasomotor dis-
charges that emanate from RVLM [23]. We also
computed the baroreflex effectiveness index (BEI) based
on online detection of spontaneous baroreflex sequences
(BRS10a, Notocord), which were detected when SBP
and pulse interval increased or decreased simultaneously
[24]. As an index for baroreflex-mediated regulation of
cardiac responses, BEI is defined as the total number of
sequences divided by the total number of pressure
ramps in each analysis zone.
Intravenous administration of methamphetamine
METH was obtained from the Food and Drug Adminis-
tration, Department of Health, Executive Yuan, Taipei,
Taiwan. METH and saline (vehicle control) were admi-
nistered intravenously. Temporal changes in pulsatile
AP, mean AP (MAP), HR, power density of the LF com-
ponent of SBP signals and BEI were routinely followed
for 240 min after intravenous administration of METH
in an on-line and real-time manner [25,26]. The survival
time and survival rate within 240 min were also
recorded.
Collection of tissue samples from brain and heart
We routinely collected tissue samples from RVLM,
CVLM, NTS, NACC, GPi, Cd, SN, VTA and heart at 20
or 240 min after the administration of METH or saline.
Animals were killed with an overdose of pentobarbital
sodium and neural tissues were collected bilaterally by
micropunches according to their anatomical boundaries;
cardiac tissues were collected directly from the left
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ventricle. The concentration of total proteins extracted
from those tissue samples was determined by the BCA
protein assay (Pierce, Rockford, IL, USA).
Determination of METH in tissue samples
The concentration of METH in cell lysate extracted
from RVLM, CVLM, NTS, NACC, GPi, Cd, SN, VTA
or heart was determined according to the manufac-
turer’s protocol of a commercial METH indirect
enzyme-linked immunosorbent assay (ELISA) kit (Cal-
biotech, Spring Valley, CA, USA), in conjunction with
spectrophotometric determination (Multiskan Spectrum,
Thermo Fisher Scientific Waltham, MA, USA) of the
absorbance of reaction solution at 450 nm [27,28].
Statistical analysis
All values are expressed as mean ± SEM. The temporal
effects of METH or saline treatments on MAP, HR,
power density of the LF component of SBP signals, BEI
or tissue METH concentration were assessed using one-
way or two-way analysis of variance (ANOVA) with
repeated measures, as appropriate, for group means. In
both cases, Scheffé multiple-range test was used for post
hoc comparison of individual means. Mortality was
assessed with the Fisher Exact Test. Correlation between
tissue METH concentration in RVLM and BEI or power
density of LF component of SBP signals was determined
by linear regression analysis. P <0.05 was considered to
be statistically significant.
Results
Differential distribution of METH to brain and heart
tissues after intravenous administration
Figure 1 shows that on intravenous administration,
METH (12 or 24 mg/kg) exhibited a time-dependent
distribution in brain and heart. While maintaining a
dose-relationship, the concentration of METH in brain
and heart tissues 20 min after administration of the two
doses was approximately double that when measured at
240 min. Detailed analysis revealed two interesting
observations. First, the distribution to the heart, a com-
monly mentioned target for cardiovascular effects of
METH [1,29,30], was significantly less than brain tissues.
Second, the concentration of METH was significantly
higher in neural substrates associated with brain stem
cardiovascular regulation (RVLM, CVLM or NTS) than
brain targets for its psychological and neurological
effects (NACC, GPi, Cd, SN or VTA).
METH dose-dependently reduces survival
Given at 12 mg/kg, i.v. administration of METH elicited
a 25% reduction in survival rate at 240 min, which
increased to 50% at a dose of 24 mg/kg (Figure 2).
Similarly, METH (12 or 24 mg/kg, i.v.) induced a dose-
dependent reduction in survival time (Figure 2).
Depressed brain stem cardiovascular regulation in rats
that survived METH intoxication
The observation that METH manifested the highest
concentration in RVLM, CVLM and NTS and the low-
est concentration in heart among all tissues studied on
systemic administration implies that this psychostimu-
lant may effect circulatory depression not directly on
the heart but indirectly via an action on the brain stem
cardiovascular regulatory process. Our third series of
experiments evaluated this possibility. In animals that
survived METH (12 or 24 mg/kg, i.v.), there was a sig-
nificant and dose-dependent drop in MAP that peaked
at 20 min, followed by a gradual return to baseline (Fig-
ure 3). HR was essentially maintained in rats that
Figure 1 Differential distribution of methamphetamine to brain
and heart tissues after intravenous administration. Changes in
methamphetamine (METH) concentration in rostral ventrolateral
medulla (RVLM), caudal ventrolateral medulla (CVLM), nucleus
tractus solitarii (NTS), nucleus accumbens (NACC), globus pallidas
(GPi), caudate nucleus (Cd), substantia nigra (SN), ventral tegmental
area (VTA) or heart (H) collected from rats 20 min (gray bar) or 240
min (hatched bars) after intravenous administration of METH at 12
mg/kg (M12) or 24 mg/kg (M24). Values are mean ± SEM, n = 4-6
animals per experimental group. Red dotted line represents the
mean value of METH concentration in RVLM, CVLM and NTS and
blue dotted line represents the mean value of METH concentration
in NACC, GPi, Cd, SN and VTA. Whereas#P < 0.05 versus heart tissue
exists in all four subsets, it is only denoted in one subset for clarity.
*P < 0.05 versus 20 min group at corresponding dose, and+P < 0.05
versus M12 group at corresponding time-points in the post hoc
Scheffé multiple-range test.
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received the lower dose of METH, despite an initial
drop at 20 min. On the other hand, there was progres-
sive bradycardia in animals that received the higher dose
of METH, with a sustained HR at 200-240 min (Figure
3). Concurrent evaluation of BEI showed an initial aug-
mentation that peaked at 40 min after the administra-
tion of METH (12 or 24 mg/kg, i.v.). Whereas BEI
returned to baseline in animals that received the lower
dose, it underwent a graduate reduction that stabilized
at 180-240 min after receiving the higher dose (Figure
3). On the other hand, with the exception of a transient
increase at 20 min after administration of METH at 12
mg/kg, both doses elicited a progressive decrease in the
power density of LF component of SBP signals over the
first 60 min. The LF power, however, lingered subse-
quently at a low level over the next 120 min (Figure 3).
Defunct brain stem cardiovascular regulation in rats that
succumbed to METH intoxication
A drastically different picture was revealed in animals that
succumbed to METH within 240 min after administration
(Figure 4). The initial drop in MAP or HR during the first
20 min seen in animals that survived was followed by a
continuous reduction that reached zero 180-220 min after
METH administration (12 or 24 mg/kg, i.v.). The initial
augmentation of BEI gave way to immediate reduction
that became zero at 180 (24 mg/kg) or 220 (12 mg/kg)
min. Likewise, the LF power underwent an abrupt
decrease and disappeared at 180-220 min. Of note is that
the time course of disappearance of MAP, HR, BEI or
power density of LF component of SBP signals (Figure 4)
was commensurate with the survival time (Figure 2)
induced by METH (12 or 24 mg/kg, i.v.).
Fatality from METH intoxication correlates with its
distribution in brain
Our final series of experiments addressed the issue of
whether depressed or defunct brain stem cardiovascular
Figure 2 METH dose-dependently reduces survival rate and
survival time. Dose-dependent changes in survival rate and survival
time in rats that received intravenous administration of METH or
saline (Sal, vehicle control). Values are mean ± SEM, n = 5-16
animals per experimental group at the beginning of the
experiment. *P < 0.05 versus saline group in the Fisher Exact Test.
Figure 3 Depressed brain stem cardiovascular regulation in
rats that survived METH intoxication. Temporal changes in
averaged values of mean arterial pressure (MAP), heart rate (HR),
baroreflex effectiveness index (BEI) or power density of the low-
frequency (LF) component of systolic blood pressure at 20 min
intervals in rats that survived intravenous administration of METH
(12 or 24 mg/kg; at arrow) or their saline (Sal) controls. Values are
mean ± SEM, n = 4-12 animals per experimental group. Note that
whereas statistical difference (P < 0.05) versus saline group exists in
the post hoc Scheffé multiple-range test at corresponding time-
points, a single notation (*) is provided for clarity.
Li et al. Journal of Biomedical Science 2012, 19:16
http://www.jbiomedsci.com/content/19/1/16
Page 4 of 7
regulation, which dictates survival or death from METH,
depends on the distribution of METH to brain stem
nuclei that are associated with this homeostatic machin-
ery. We found that the concentration of METH in
RVLM, a key neural substrate in brain stem cardiovas-
cular regulation, was positively and significantly corre-
lated with the reduction in BEI and power density of LF
component of SBP signals (Figure 5).
Discussion
The present study revealed two pieces of novel informa-
tion regarding METH. First, on intravenous administra-
tion, this psychostimulant exhibited the largest
distribution to brain stem nuclei that are associated with
the baroreflex loop, followed by brain targets that are
involved in the manifestation of its neurological and
psychological responses; the concentration of METH in
cardiac tissues was the lowest among all tissues studied.
Second, METH effects acute cardiovascular depression
by dampening the functional integrity of baroreflex, the
degree of which correlated directly with its concentra-
tion in the relevant brain stem nuclei.
We chose to employ intravenous administration of
METH in the present study because this is a common
route [31] that is employed by abusers to rapidly raise
the blood concentration of METH to euphoric levels.
METH is more lipid-soluble than its primary metabolite
amphetamine, with enhanced transport across the
blood-brain barrier and stability against enzymatic
degradation by monoamine oxidase [32]. Whereas the
dose-dependent and time-dependent pharmacokinetics
data are in accordance with its chemical properties, we
found that instead of NACC, GPi, Cd, SN and VTA,
which are involved in the manifestation of its well-
known pharmacological effects, the highest concentra-
tion of METH was present in RVLM, CVLM and NTS,
Figure 4 Defunct brain stem cardiovascular regulation in rats
that succumbed to METH intoxication. Temporal changes in
averaged values of MAP, HR, BEI or power density of the LF
component of systolic blood pressure at 20 min intervals in rats
that succumbed to intravenous administration of METH (12 or 24
mg/kg; at arrow) or in their saline (Sal) controls.. Values are mean ±
SEM, n = 4-5 animals per experimental group. Note that whereas
statistical difference (P < 0.05) versus saline group exists in the post
hoc Scheffé multiple-range test at corresponding time-points, a
single notation (*) is provided for clarity.
Figure 5 Fatality from METH intoxication correlates with its
distribution in brain. Linear regression analysis of the relationship
between concentration of METH in RVLM and BEI or power density
of the LF component of systolic blood pressure. Dotted lines
denote 95% confidence intervals, and r2 denotes coefficient of
correlation.
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brain stem nuclei that are associated with the baroreflex
circuitry. The ability to maintain a stable AP and HR in
the form of baroreflex is essential to humans and ani-
mals alike. Inputs from primary baroreceptor afferents
synapse at NTS. Outputs from NTS promote modula-
tion of vagal and sympathetic outflow to the heart and
peripheral vasculature via the CVLM and RVLM [20]. It
is therefore intriguing that the preferential distribution
of METH bears functional implications to METH intox-
ication. In animals that succumbed to METH, the baror-
eflex-mediated sympathetic vasomotor tone (LF power)
and cardiac response (BEI) failed to function (defunct
brain stem cardiovascular regulation), leading to the ces-
sation of AP and HR. On the other hand, the power
density of LF component of SBP signals and BEI, which
either returned to baseline or decreased but stabilized
above zero (depressed brain stem cardiovascular regula-
tion) in animals that survived the two doses of METH
studied, were sufficient to sustain AP and HR.
We recognize that METH may also act directly on the
heart when administered intravenously, leading to heart
failure in patients died of METH [1,29,30]. Whereas the
design of our study does not allow us to repudiate this
notion, the possibility for depression of cardiac func-
tions, rather than failure of brain stem cardiovascular
regulation, to be primarily responsible for METH-
induced cardiovascular collapse is discernibly reduced
by our observation that the distribution of METH to
cardiac tissues was significantly less than to brain tar-
gets. Furthermore, successful resuscitation of an arrested
heart depends on maintained functionality of brain stem
cardiovascular regulation [19], suggesting that this
homeostatic process, rather than the heart, holds the
key to cardiovascular collapse.
METH abusers have to constantly increase dosing to
sustain an elevated mood and libido and a decrease in
appetite and fatigue. At the same time, continuous use
at larger doses results in not only acute METH poi-
soning but also METH-induced sudden death
[16,29,30]. Our novel pharmacokinetics findings offer
a reasonable mechanistic underpinning for this phe-
nomenon. We found that the extent that brain stem
cardiovascular regulation is dampened is dependent
on the concentration of METH in brain stem sites
associated with this homeostatic process. An impor-
tant ramification that arises from this observation is
that accompanying the increase in dosing of METH
and the sustained euphoric effects is the enhanced
possibility for the depressed brain stem cardiovascular
regulation to become defunct, leading to cardiovascu-
lar collapse. Since METH was determined in cell
lysate extracted from the tissue samples, it is possible
that our measurements simply represent accumulation
of METH and bear no functional relevance. This pos-
sibility is deemed unlikely for at least two reasons.
First, we demonstrated that the concentration of
METH measured in RVLM, a key neural substrate in
brain stem cardiovascular regulation, was positively
and significantly correlated with the reduction in BEI
and power density of LF component of SBP signals.
Second, recent studies from our laboratory [33] indi-
cated that the concentration of METH in the extracel-
lular fluid collected by microdialysis from RVLM 10
min after intravenous administration is already 10
times higher than that in serum, approaching a pla-
teau within 20 min.
A majority of the literature on METH concerns pri-
marily with behavioral alterations, physical dependence
or psychopathology of withdrawal syndrome and its
management that is associated with this psychostimu-
lant. Much less studies are devoted to the mechanisms
of cardiovascular collapse associated with METH intoxi-
cation despite that it is a common cause of death within
the abuse population, [14,15]. The present study
revealed that in addition to the brain targets that are
associated with the reward system and neurodegenera-
tive diseases, METH exhibits a preferential distribution
to brain stem nuclei that are associated with cardiovas-
cular regulation on intravenous administration. We
further found that the concentration of METH in those
brain stem sites dictates the extent that baroreflex-
mediated sympathetic vasomotor tone and cardiac
responses are compromised, which in turn determines
survival or fatality because of cardiovascular collapse.
This information should offer novel leads for devising
clinical management or developing therapeutic strategies
against the increasing number of sudden death from
METH abusers.
Conclusion
In conclusion, the present study revealed that by exhi-
biting the largest distribution to brain stem nuclei that
are associated with the baroreflex loop on intravenous
administration, METH effects acute cardiovascular
depression by dampening the functional integrity of this
fundamental homeostatic mechanism in brain stem car-
diovascular regulation.
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